Definitive Healthcare (NASDAQ:DH) Releases FY24 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $0.36-$0.38 for the period, compared to the consensus EPS estimate of $0.38. The company issued revenue guidance of $255-261 million, compared to the consensus revenue estimate of $266.31 million. Definitive Healthcare also updated its Q2 guidance to $0.08-$0.09 EPS.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Stifel Nicolaus dropped their price target on Definitive Healthcare from $11.00 to $9.50 and set a buy rating for the company in a research report on Wednesday. Deutsche Bank Aktiengesellschaft cut their target price on Definitive Healthcare from $10.00 to $7.00 and set a hold rating on the stock in a research report on Thursday. Barclays lowered their price target on Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating for the company in a research report on Thursday. Canaccord Genuity Group cut their price objective on shares of Definitive Healthcare from $10.00 to $8.00 and set a hold rating on the stock in a research report on Wednesday. Finally, Morgan Stanley lowered shares of Definitive Healthcare from an overweight rating to an equal weight rating and lowered their target price for the stock from $11.50 to $9.00 in a report on Wednesday. Nine analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of Hold and an average price target of $9.94.

Definitive Healthcare Trading Down 3.4 %

Shares of NASDAQ:DH traded down $0.18 during trading on Thursday, reaching $5.17. 3,323,524 shares of the company were exchanged, compared to its average volume of 643,916. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.31 and a quick ratio of 2.31. The firm has a market capitalization of $608.97 million, a PE ratio of -2.86, a P/E/G ratio of 6.12 and a beta of 1.41. The business’s fifty day simple moving average is $7.70 and its 200-day simple moving average is $8.29. Definitive Healthcare has a 12-month low of $4.38 and a 12-month high of $12.45.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The firm had revenue of $65.93 million for the quarter, compared to analysts’ expectations of $66.01 million. On average, research analysts anticipate that Definitive Healthcare will post 0.11 EPS for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.